DK1076561T3 - Kombinationsterapi til behandlingen af tumorer - Google Patents

Kombinationsterapi til behandlingen af tumorer

Info

Publication number
DK1076561T3
DK1076561T3 DK99921972T DK99921972T DK1076561T3 DK 1076561 T3 DK1076561 T3 DK 1076561T3 DK 99921972 T DK99921972 T DK 99921972T DK 99921972 T DK99921972 T DK 99921972T DK 1076561 T3 DK1076561 T3 DK 1076561T3
Authority
DK
Denmark
Prior art keywords
combination therapy
tumors
treatment
gastrin
combination
Prior art date
Application number
DK99921972T
Other languages
English (en)
Inventor
Philip C Gevas
Stephen Grimes
Dov Michaeli
Stephen L Karr
Susan A Watson
Original Assignee
Aphton Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aphton Corp filed Critical Aphton Corp
Application granted granted Critical
Publication of DK1076561T3 publication Critical patent/DK1076561T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK99921972T 1998-05-15 1999-05-14 Kombinationsterapi til behandlingen af tumorer DK1076561T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8568798P 1998-05-15 1998-05-15
PCT/US1999/010750 WO1999059628A2 (en) 1998-05-15 1999-05-14 Combination therapy for the treatment of tumors

Publications (1)

Publication Number Publication Date
DK1076561T3 true DK1076561T3 (da) 2005-06-06

Family

ID=22193286

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99921972T DK1076561T3 (da) 1998-05-15 1999-05-14 Kombinationsterapi til behandlingen af tumorer

Country Status (16)

Country Link
EP (1) EP1076561B1 (da)
JP (1) JP2002515457A (da)
KR (1) KR100699574B1 (da)
CN (1) CN1216605C (da)
AT (1) ATE291918T1 (da)
AU (1) AU745749B2 (da)
CA (1) CA2327439C (da)
DE (1) DE69924483T2 (da)
DK (1) DK1076561T3 (da)
ES (1) ES2237103T3 (da)
HK (1) HK1032360A1 (da)
HU (1) HUP0101947A3 (da)
PL (1) PL193109B1 (da)
PT (1) PT1076561E (da)
WO (1) WO1999059628A2 (da)
ZA (1) ZA200005962B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030091574A1 (en) * 2001-03-23 2003-05-15 Gevas Philip C. Combination treatment of pancreatic cancer
AU2002326356A1 (en) * 2001-07-09 2003-01-29 Aphton Corporation Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
CA2489919A1 (en) * 2002-07-03 2004-01-15 Aphton Corporation Liposomal vaccine
EP1608984A2 (en) 2003-03-28 2005-12-28 Aphton Corporation Gastrin hormone immunoassays
US20050053664A1 (en) * 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
CN101797382B (zh) * 2010-03-03 2013-11-20 戚胜美 抗人前胃液素多肽免疫组合物
US8674064B2 (en) 2010-03-03 2014-03-18 Onkologix Ltd Immunogenic compositions against human progastrin peptides
EA201100464A1 (ru) * 2011-04-06 2012-10-30 Ооо "Метамакс" (Ооо "Метамах") Фармацевтическая композиция для лечения гиперпролиферативных заболеваний и её применение
PL3071206T3 (pl) 2013-11-22 2022-01-17 CL BioSciences LLC Antagoniści gastryny (eg yf476, netazepid) do leczenia i zapobiegania osteoporozie
EP3624841A4 (en) 2017-06-15 2021-01-27 Cancer Advances, Inc., COMPOSITIONS AND METHODS OF INDUCING HUMORAL AND CELLULAR IMMUNITIES AGAINST TUMORS AND CANCER

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341281C (en) * 1986-07-09 2001-08-07 Hubert J.P. Schoemaker Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen
ATE114160T1 (de) * 1989-01-24 1994-12-15 Aphton Corp Immunogenische zusammensetzungen gegen gastrin- peptide.
US5468494A (en) * 1993-11-12 1995-11-21 Aphton Corp. Immunogenic compositions against human gastrin 17

Also Published As

Publication number Publication date
DE69924483T2 (de) 2006-02-09
HK1032360A1 (en) 2001-07-20
CN1216605C (zh) 2005-08-31
ATE291918T1 (de) 2005-04-15
AU745749B2 (en) 2002-03-28
KR20010052355A (ko) 2001-06-25
CA2327439C (en) 2005-07-05
CA2327439A1 (en) 1999-11-25
JP2002515457A (ja) 2002-05-28
PL193109B1 (pl) 2007-01-31
KR100699574B1 (ko) 2007-03-23
WO1999059628A3 (en) 2000-01-13
WO1999059628A2 (en) 1999-11-25
CN1303288A (zh) 2001-07-11
ZA200005962B (en) 2002-01-24
HUP0101947A2 (hu) 2001-11-28
EP1076561A2 (en) 2001-02-21
HUP0101947A3 (en) 2001-12-28
DE69924483D1 (de) 2005-05-04
EP1076561B1 (en) 2005-03-30
ES2237103T3 (es) 2005-07-16
PT1076561E (pt) 2005-08-31
AU3904599A (en) 1999-12-06
PL344414A1 (en) 2001-11-05

Similar Documents

Publication Publication Date Title
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
CY2473B1 (en) New phenanthridines.
EA200000994A1 (ru) Применение кабэрголина при лечении синдрома усталых ног
TW366342B (en) The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
MD1616G2 (ro) Compuşi triciclici şi metodă de inhibare a receptorului tirozin kinazei pentru factorul de creştere epidermic, compoziţie farmaceutică, metode de prevenire a implantării blastocitului şi tratament al mamiferelor
BG100517A (en) Combination of bisphosphonates and growth hormone secretagogues
EA200000220A1 (ru) Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы
IL125590A (en) Peptide immunogens, process for their preparation and use thereof as vaccines against allergies
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
SE9404196D0 (sv) New antithrombotic formulation
IL98258A0 (en) Composition for treating impotence containing doxazosin,amlodipine,or u.k.52,046
UA41355C2 (uk) Засіб для лікування нейро-сніду
GR3022321T3 (en) Use of il-4 to treat solid tumors
DK1076561T3 (da) Kombinationsterapi til behandlingen af tumorer
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
DE69316013T2 (de) Verwendung von phosphinate zur behandlung der osteoporose
SE9603725D0 (sv) New teatment
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
MX9701187A (es) Nuevas lactamas naftofusionadas n-substituidas.
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
MXPA01007952A (es) Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas.